liraglutide

Generic: liraglutide

Labeler: teva pharmaceuticals usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA AUTHORIZED GENERIC Inactive Finished

Drug Facts

Product Profile

Brand Name liraglutide
Generic Name liraglutide
Labeler teva pharmaceuticals usa, inc.
Dosage Form INJECTION
Routes
SUBCUTANEOUS
Active Ingredients

liraglutide 6 mg/mL

Manufacturer
Teva Pharmaceuticals USA, Inc.

Identifiers & Regulatory

Product NDC 0480-3667
Product ID 0480-3667_57c9f463-a1b8-4efa-8982-40175cf6cf4f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA AUTHORIZED GENERIC
Application Number NDA022341
Listing Expiration 2027-12-31
Marketing Start 2024-06-24

Pharmacologic Class

Established (EPC)
glp-1 receptor agonist [epc]
Mechanism of Action
glucagon-like peptide-1 (glp-1) agonists [moa]
Chemical Structure
glucagon-like peptide 1 [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 04803667
Hyphenated Format 0480-3667

Supplemental Identifiers

RxCUI
897122
UNII
839I73S42A
NUI
N0000178480 M0160181 N0000020058

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name liraglutide (source: ndc)
Generic Name liraglutide (source: ndc)
Application Number NDA022341 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 6 mg/mL
source: ndc
Packaging
  • 2 SYRINGE, PLASTIC in 1 CARTON (0480-3667-20) / 3 mL in 1 SYRINGE, PLASTIC (0480-3667-19)
  • 3 SYRINGE, PLASTIC in 1 CARTON (0480-3667-22) / 3 mL in 1 SYRINGE, PLASTIC (0480-3667-19)
source: ndc

Packages (2)

0480-3667-20 2 SYRINGE, PLASTIC in 1 CARTON (0480-3667-20) / 3 mL in 1 SYRINGE, PLASTIC (0480-3667-19) 0480-3667-22 3 SYRINGE, PLASTIC in 1 CARTON (0480-3667-22) / 3 mL in 1 SYRINGE, PLASTIC (0480-3667-19)

Ingredients (1)

liraglutide (6 mg/mL)

Linked Drug Pages (1)

Liraglutide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "57c9f463-a1b8-4efa-8982-40175cf6cf4f", "openfda": {"nui": ["N0000178480", "M0160181", "N0000020058"], "unii": ["839I73S42A"], "rxcui": ["897122"], "spl_set_id": ["14bf9812-14ee-46ce-93b1-686e4906cbbc"], "pharm_class_cs": ["Glucagon-Like Peptide 1 [CS]"], "pharm_class_epc": ["GLP-1 Receptor Agonist [EPC]"], "pharm_class_moa": ["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 SYRINGE, PLASTIC in 1 CARTON (0480-3667-20)  / 3 mL in 1 SYRINGE, PLASTIC (0480-3667-19)", "package_ndc": "0480-3667-20", "marketing_start_date": "20240624"}, {"sample": false, "description": "3 SYRINGE, PLASTIC in 1 CARTON (0480-3667-22)  / 3 mL in 1 SYRINGE, PLASTIC (0480-3667-19)", "package_ndc": "0480-3667-22", "marketing_start_date": "20240624"}], "brand_name": "Liraglutide", "product_id": "0480-3667_57c9f463-a1b8-4efa-8982-40175cf6cf4f", "dosage_form": "INJECTION", "pharm_class": ["GLP-1 Receptor Agonist [EPC]", "Glucagon-Like Peptide 1 [CS]", "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "product_ndc": "0480-3667", "generic_name": "liraglutide", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Liraglutide", "active_ingredients": [{"name": "LIRAGLUTIDE", "strength": "6 mg/mL"}], "application_number": "NDA022341", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20240624", "listing_expiration_date": "20271231"}